Opening book details…
About this Medicine article
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway by Herbertz, Stephan (author);Sawyer, J. Scott (author);Stauber, Anja J. (author);Gueorguieva, Ivelina (author);Driscoll, Kyla E. (author);Estrem, Shawn T. (author);Cleverly, Ann L. (author);Desaiah, Durisala (author);Guba, Susan C. (author);Benhadji, Karim A. (author);Slapak, Christopher A. (author);Lahn, Michael M. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Herbertz, Stephan (author);Sawyer, J. Scott (author);Stauber, Anja J. (author);Gueorguieva, Ivelina (author);Driscoll, Kyla E. (author);Estrem, Shawn T. (author);Cleverly, Ann L. (author);Desaiah, Durisala (author);Guba, Susan C. (author);Benhadji, Karim A. (author);Slapak, Christopher A. (author);Lahn, Michael M. (author)
- Publisher
- Dove Medical Press Ltd.
- Published
- 2015
- Field
- Medicine (Health Sciences)